PHARMACEUTICAL COMPOSITION CONTAINING HISTONE DEACETYLASE INHIBITOR

An anticancer drug having a synergistic effect by combined use of a histone acetylase derivative such as N-(2-aminophenyl)-4-[N- (pyridin-3- ylmethoxycarbonyl) aminomethyl]benzamide (MS-275) and another anticancer active substance. Opisan je lek protiv raka koji obezbeđuje sinergističko dejstvo deri...

Full description

Saved in:
Bibliographic Details
Main Authors NAKANISHI OSAMU, MIGITA HIDEYUKI, SUGAWARA TAISUO, MATSUBA YASUHIRO
Format Patent
LanguageEnglish
Serbian
Published 04.04.2008
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:An anticancer drug having a synergistic effect by combined use of a histone acetylase derivative such as N-(2-aminophenyl)-4-[N- (pyridin-3- ylmethoxycarbonyl) aminomethyl]benzamide (MS-275) and another anticancer active substance. Opisan je lek protiv raka koji obezbeđuje sinergističko dejstvo derivata benzamida, kao što N-(2-aminofenil)-4-[N-(piridin-3-ilmetoksikarbonil)aminoetil]benzamid (MS-275), koji je inhibitor histonske deacetilaze, prilikom kombinovane upotrebe sa još jednom aktivnom antikancerskom supstancom.
Bibliography:Application Number: YU2005P000884